
|

Rothwell, Figg Named "the Leading Law Firm in Generic Drug Law"
Rothwell, Figg is referred to as "the leading law firm in generic drug law" when Steven Lieberman was interviewed with respect to legal costs associated with challenging a patent versus the potential profitability time table if the generic drug firm breaks a patent. "Generic Drug Makers: Accept No Substitutes," MSN Money, Aug. 3, 2001. |